Histamine-succinyl-glycine hapten (HSG hapten)

Histamine-succinyl-glycine hapten (**HSG**) is a synthetic small molecule composed of histamine conjugated via succinic acid to glycine. It functions **not** as a biological target such as a receptor or enzyme but rather as an artificial epitope (“hapten”) designed to be specifically recognized by engineered antibodies. The primary application of the HSG motif is in **pretargeted radioimmunotherapy and molecular imaging**, where it enables highly specific binding between bispecific monoclonal antibodies and radiolabeled peptide probes containing one or more copies of the HSG sequence[3][5]. For example, peptides like IMP288 and IMP243 incorporate one or two copies of this motif to allow selective targeting by anti-HSG antibody fragments that have been directed toward tumor antigens[3][4]. The design allows flexible conjugation with various reporter molecules—such as chelators for radiometals (^68Ga, ^111In), fluorescent dyes, or drugs—making it valuable for multimodal imaging applications[1]. The system improves tumor-to-background ratios during imaging because unbound labeled haptens clear rapidly from circulation while only those bound via bispecific antibodies accumulate at target sites. **Importantly**, “histamine-succinyl-glycine hapten” should not be considered a therapeutic target on its own—it has no endogenous biological function nor disease association outside its role in engineered targeting systems. Its main value lies in enabling modular assembly of targeted diagnostic/therapeutic agents through high-affinity antibody-hapten interactions[1][3]. If you require structured information about actual therapeutic targets involved in these systems (e.g., HER2 receptor), please specify accordingly. --- **Note:** This entry represents an *artificial chemical tag* used primarily in research and clinical development settings—not an endogenous protein/receptor/enzyme found naturally within human biology.

Other names

HSGHistamine-succinyl-glycine (HSG) motifHim-Suc-Glydi-HSG (for bivalent forms)HSG-peptide

Hapten does not have intrinsic pharmacological action; it serves as an epitope recognized by anti-HSG antibodies.